BTI
ABBV icon

Blue Trust Inc’s AbbVie ABBV Stock Holding History

Blue Trust Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Buy
42,082
+1,463
+4% +$315K 0.11% 60
2026
Q1 		$8.83M Sell
40,619
-4,863
-11% -$1.08M 0.1% 62
2025
Q4 		$10.4M Sell
45,482
-1,017
-2% -$232K 0.12% 60
2025
Q3 		$10.8M Buy
46,499
+486
+1% +$99K 0.12% 58
2025
Q2 		$8.54M Sell
46,013
-1,590
-3% -$295K 0.1% 66
2025
Q1 		$9.97M Sell
47,603
-568
-1% -$110K 0.13% 56
2024
Q4 		$8.56M Buy
48,171
+8,959
+23% +$1.65M 0.11% 62
2024
Q3 		$6.73M Buy
39,212
+11,444
+41% +$2.14M 0.09% 66
2024
Q2 		$5.06M Buy
27,768
+2,843
+11% +$471K 0.07% 75
2024
Q1 		$4.54M Sell
24,925
-455
-2% -$78.4K 0.06% 68
2023
Q4 		$3.78M Buy
25,380
+1,607
+7% +$234K 0.06% 69
2023
Q3 		$3.2M Buy
23,773
+1,172
+5% +$172K 0.05% 79
2023
Q2 		$3.6M Sell
22,601
-6,636
-23% -$973K 0.06% 74
2023
Q1 		$4.72M Sell
29,237
-361
-1% -$55.2K 0.08% 75
2022
Q4 		$3.97M Buy
29,598
+4,362
+17% +$669K 0.07% 73
2022
Q3 		$3.87M Buy
25,236
+1,777
+8% +$255K 0.07% 69
2022
Q2 		$3.8M Buy
+23,459
New +$3.58M 0.06% 72

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Blue Trust Inc's ABBV Position: Q2 2026 in Review

Blue Trust Inc increased its AbbVie (ABBV) stake by 3.6% in Q2 2026, buying an estimated $315K and bringing the position to 42,082 shares worth $10.6M. The position accounts for 0.11% of the portfolio, ranked #60.

Blue Trust Inc first reported a position in ABBV in Q2 2022 and has held it in 17 quarters since. The position peaked at $10.8M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Blue Trust Inc held 42,082 shares of AbbVie worth $10.6M as of Q2 2026.
  • Blue Trust Inc bought 1,463 AbbVie shares in Q2 2026, an estimated $315K.
  • AbbVie made up 0.11% of Blue Trust Inc's portfolio in Q2 2026, its #60 holding.
  • Blue Trust Inc first reported a position in AbbVie in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's AbbVie position peaked at $10.8M in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.